Argenx has a total of 202 patents globally, out of which 67 have been granted. Of these 202 patents, more than 76% patents are active. The United States of America is where Argenx has filed the maximum number of patents, followed by Europe and Australia. Parallelly, The United Kingdom seems to be the main focused R&D center and also Netherlands is the origin country of Argenx.
Argenx was founded in 2008. The Company operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer.
Do read about some of the most popular patents of Argenx which have been covered by us in this article and also you can find Argenx patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Argenx patent portfolio.
How many patents does the Founder and CEO of Argenx have?
The Founder and the CEO Tim Van Hauwermeiren has 38 patents.
How many patents does Argenx have?
Argenx has a total of 202 patents globally. These patents belong to 47 unique patent families. Out of 202 patents, 154 patents are active.
How Many Patents did Argenx File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Argenx Applications Filed | Argenx Patents Granted |
2023 | 4 | 3 |
2022 | 22 | 26 |
2021 | 30 | 7 |
2020 | 15 | 4 |
2019 | 19 | 3 |
2018 | 25 | 4 |
2017 | 4 | 7 |
2016 | 9 | 7 |
2015 | 13 | 1 |
2014 | 18 | 3 |
2013 | 19 | 2 |
2012 | 7 | – |
How many Argenx patents are Alive/Dead?
Worldwide Patents
How Many Patents did Argenx File in Different Countries?
Countries in which Argenx Filed Patents
Country | Patents |
United States Of America | 49 |
Europe | 13 |
Australia | 12 |
New Zealand | 10 |
Canada | 9 |
United Kingdom | 9 |
India | 9 |
Singapore | 8 |
Israel | 6 |
South Africa | 5 |
Brazil | 5 |
Mexico | 5 |
Indonesia | 5 |
Hong Kong (S.A.R.) | 4 |
Japan | 3 |
Spain | 2 |
Hungary | 2 |
Chile | 2 |
Italy | 2 |
Norway | 2 |
Serbia | 1 |
Croatia | 1 |
Slovenia | 1 |
Austria | 1 |
Poland | 1 |
Taiwan | 1 |
Germany | 1 |
Colombia | 1 |
Slovakia | 1 |
Peru | 1 |
Philippines | 1 |
Denmark | 1 |
Korea (South) | 1 |
Ecuador | 1 |
Lithuania | 1 |
Where are Research Centers of Argenx Patents Located?
10 Best Argenx Patents
WO2011080350A1 is the most popular patent in the Argenx portfolio. It has received 55 citations so far from companies like Evec Co. Ltd, Cardio3 Biosciences S.A. and Staten Biotechnology B.V.
Below is the list of 10 most cited patents of Argenx:
Publication Number | Citation Count |
WO2011080350A1 | 55 |
WO2016125017A1 | 39 |
WO2016026943A1 | 38 |
WO2012123586A1 | 36 |
WO2015100299A1 | 33 |
WO2012059561A1 | 30 |
US8834882B2 | 27 |
WO2012059562A1 | 25 |
WO2014033252A1 | 24 |
US9765148B2 | 22 |
What Percentage of Argenx US Patent Applications were Granted?
Argenx (Excluding its subsidiaries) has filed 46 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 32 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Argenx patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Argenx?
Law Firm | Total Applications | Success Rate |
Lathrop Gpm | 25 | 100.00% |
Dechert | 21 | 100.00% |
hat are Argenx key innovation segments?
What Technologies are Covered by Argenx?
The chart below distributes patents filed by Argenx